Authors:
LaRochelle, WJ
Jeffers, M
McDonald, WF
Chillakuru, RA
Giese, NA
Lokker, NA
Sullivan, C
Boldog, FL
Yang, MJ
Vernet, C
Burgess, CE
Fernandes, E
Deegler, LL
Rittman, B
Shimkets, J
Shimkets, RA
Rothberg, JM
Lichenstein, HS
Citation: Wj. Larochelle et al., PDGFD, a new protease-activated growth factor, NAT CELL BI, 3(5), 2001, pp. 517-521
Authors:
Xiao, GH
Jeffers, M
Bellacosa, A
Mitsuuchi, Y
Vande Woude, GF
Testa, JR
Citation: Gh. Xiao et al., Anti-apoptotic signaling by hepatocyte growth factor/Met via the phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase pathways, P NAS US, 98(1), 2001, pp. 247-252
Authors:
Jeffers, M
Shimkets, R
Prayaga, S
Boldog, F
Yang, MJ
Burgess, C
Fernandes, E
Rittman, B
Shimkets, J
LaRochelle, WJ
Lichtenstein, HS
Citation: M. Jeffers et al., Identification of a novel human fibroblast growth factor and characterization of its role in oncogenesis, CANCER RES, 61(7), 2001, pp. 3131-3138
Authors:
Gladstone, HB
Nguyen, SL
Williams, R
Ottomeyer, T
Wortzman, M
Jeffers, M
Moy, RL
Citation: Hb. Gladstone et al., Efficacy of hydroquinone cream (USP 4%) used alone or in combination with salicylic acid peels in improving photodamage on the neck and upper chest, DERM SURG, 26(4), 2000, pp. 333-337
Authors:
Webb, CP
Hose, CD
Koochekpour, S
Jeffers, M
Oskarsson, M
Sausville, E
Monks, A
Vande Woude, GF
Citation: Cp. Webb et al., The geldanamycins are potent inhibitors of the hepatocyte growth factor/scatter factor-Met-urokinase plasminogen activator-plasmin proteolytic network, CANCER RES, 60(2), 2000, pp. 342-349
Authors:
Koo, HM
Gray-Goodrich, M
Kohlhagen, G
McWilliams, MJ
Jeffers, M
Vaigro-Wolff, A
Alvord, WG
Monks, A
Paull, KD
Pommier, Y
Vande Woude, GF
Citation: Hm. Koo et al., The ras oncogene-mediated sensitization of human cells to topoisomerase IIinhibitor-induced apoptosis, J NAT CANC, 91(3), 1999, pp. 236-244
Authors:
Ferrer, N
Garcia-Espana, A
Jeffers, M
Pellicer, A
Citation: N. Ferrer et al., The unr gene: Evolutionary considerations and nucleic acid-binding properties of its long isoform product, DNA CELL B, 18(3), 1999, pp. 209-218
Citation: M. Jeffers et Gf. Vande Woude, Activating mutations in the Met receptor overcome the requirement for autophosphorylation of tyrosines crucial for wild type signaling, ONCOGENE, 18(36), 1999, pp. 5120-5125
Authors:
Koochekpour, S
Jeffers, M
Wang, PH
Gong, CN
Taylor, GA
Roessler, LM
Stearman, R
Vasselli, JR
Stetler-Stevenson, WG
Kaelin, WG
Linehan, WM
Klausner, RD
Gnarra, JR
Vande Woude, GF
Citation: S. Koochekpour et al., The von Hippel-Lindau tumor suppressor gene inhibits hepatocyte growth factor/scatter factor-induced invasion and branching morphogenesis in renal carcinoma cells, MOL CELL B, 19(9), 1999, pp. 5902-5912
Authors:
Ried, S
Jager, C
Jeffers, M
Vande Woude, GF
Graeff, H
Schmitt, M
Lengyel, E
Citation: S. Ried et al., Activation mechanisms of the urokinase-type plasminogen activator promoterby hepatocyte growth factor scatter factor, J BIOL CHEM, 274(23), 1999, pp. 16377-16386